The Kable

The Kable

Share this post

The Kable
The Kable
💊 Pfizer keeps on expanding; Glenmark gets more US FDA love; PEPFAR wants to scale African manufacturing
Copy link
Facebook
Email
Notes
More

💊 Pfizer keeps on expanding; Glenmark gets more US FDA love; PEPFAR wants to scale African manufacturing

#232 | Dance to stay young

Vinod's avatar
Vinod
Dec 07, 2022
∙ Paid

Share this post

The Kable
The Kable
💊 Pfizer keeps on expanding; Glenmark gets more US FDA love; PEPFAR wants to scale African manufacturing
Copy link
Facebook
Email
Notes
More
Share

Hello, and welcome back to a fully-loaded Kable - a Kable so long you might need an extra day to read it all.

First up, the UK has a well-documented healthcare staffing crisis. Compounding that crisis is an impending strike called by nurses' associations. For long, the UK has been importing healthcare workers from Africa, with Nigeria and Zimbabwe being the most preferred destination for healthcare headhunters lately. However, Ghana is now looking to cash in on the British propensity for African healthcare workers by sending nurses to the UK for a £1,000 fee. The potential Ghana-UK agreement also comes with the promise that the nurses will return to Ghana after three years.

Separately, the UK NHS has launched a trial to allow patients to carry out health checks at home. We're pretty certain the staffing shortage has no role to play in this trial.

Elon Musk wants to put implants in people's brains to cure neurological illnesses. And he says the implants from his startup Neuralink will be ready within 6 months. However, employees and federal authorities are not so sure. Neuralink is currently the subject of a federal probe over animal testing with whistleblowers reporting that the company has killed nearly 1500 animals in the past 4 years, with several being killed because of human errors. Sure, this is one implant that humans will be queueing up to get.

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More